Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The parasite tegument and surface structures represent the complex, syncytial outer covering of helminths, particularly trematodes (flukes) and cestodes (tapeworms) (Frontiers in Microbiology, 2020; NIH, 2014). This unique biological interface serves as a multifunctional organ responsible for nutrient absorption, osmoregulation, waste excretion, and protection against the host's digestive enzymes and immune system (NIH, 2014; IntechOpen, 2016). In blood-dwelling parasites like schistosomes, the tegument is characterized by a specialized double-bilayer membrane known as the membranocalyx, which facilitates immune evasion through antigen masking and rapid surface turnover (NIH, 2009; NIH, 2020). Pharmacologically, the tegument is a primary target for anthelmintic drugs such as praziquantel, which induces rapid calcium influx and subsequent tegumental vacuolization and disintegration (Patsnap, 2024; Wikipedia, 2024). This structural damage exposes internal parasite antigens to the host's immune system, leading to the worm's destruction and clearance (Brighton University, 2023; IntechOpen, 2016). Understanding the molecular composition of the tegument, including its specific transporters and surface proteins like tetraspanins and aquaporins, is critical for the development of new drugs and vaccines to combat widespread parasitic infections (NIH, 2020; Frontiers in Immunology, 2022).
Anthelmintic drugs targeting the tegument typically act by disrupting membrane integrity, inducing rapid calcium influx, or causing vacuolization and disintegration of the syncytial layer, which exposes parasite antigens to the host immune system (Patsnap, 2024; NIH, 2014).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite tegument and surface structures.